Physician profile
Robert M Palacios
NPI 1093891723
$1,217.43
in general payments reported to CMS, 2019-2025
10 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $91.64 · 2021: $143 · 2022: $108 · 2023: $271 · 2024: $239 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $521.01 | 2019-2025 | Monovisc, Orthovisc |
| Ferring Pharmaceuticals INC. | $392.91 | 2019-2025 | Euflexxa |
| Kowa Pharmaceuticals America, INC. | $88.15 | 2022-2023 | Seglentis |
| Ibsa Pharma INC. | $58.50 | 2023-2024 | Tirosint, Licart, Tirosint |
| Djo, LLC | $43.52 | 2024 | Cmf |
| Pacira Therapeutics, INC. | $41.71 | 2019 | |
| Electronic Waveform Lab, INC. | $26.81 | 2024 | |
| Arthrosurface Incorporated | $18.12 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.73 | 2019 | |
| Zimmer Biomet Holdings, INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Palacios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.